Publications by authors named "Lisa D Townsend"
Article Synopsis
- The study aimed to assess family satisfaction regarding their participation in the TOSCA trial, which compared two treatment methods for severe childhood aggression.
- Out of 168 families, 150 provided feedback, showing high satisfaction: 91% would join the study again, and 98% would recommend it to others.
- Results indicated that while satisfaction levels were high regardless of treatment type, parental confidence in managing their child's behavior was strongly linked to their child's response to the treatment.
Aripiprazole in children with attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol
August 2008
Objective: To examine the effectiveness and cognitive effects of aripiprazole (APZ) in children with a primary diagnosis of attention-deficit/hyperactivity disorder (ADHD).
Methods: Youths, ages 8-12 years, with a diagnosis of ADHD combined-type or ADHD predominately inattentive-type were enrolled into a 6-week, open-label pilot trial. Outcome measures included the ADHD Rating Scale-IV (ARS-IV), Clinical Global Impressions Scale (CGI), and Children's Global Assessment Scale (CGAS).
Although recently more research has considered children with bipolar disorder than in the past, much controversy still surrounds the validity of the diagnosis. Furthermore, questions remain as to whether or not childhood expressions of bipolarity are continuous with adult manifestations of the illness. In order to advance current knowledge of bipolar disorders in children, researchers have begun to conduct phenomenological, longitudinal, treatment, and neuroimaging studies in youths who exhibit symptoms of bipolar illness, as well as offspring of parents with bipolar disorders.
View Article and Find Full Text PDFFamily conflict moderates response to pharmacological intervention in pediatric bipolar disorder.
J Child Adolesc Psychopharmacol
December 2007
Objective: Family conflict affects the expression of psychopathology in youth. This study investigated whether family conflict moderates response to medication in youth with bipolar disorder.
Methods: Youth ages 5-17 years diagnosed with bipolar I or II disorder were recruited from a trial of combination therapy with divalproex and lithium.
Children and adolescents with a bipolar disorder experience mood dysregulation that is often chronic with little interepisodic recovery. Although bipolar disorder in youth is recognized by more and more clinicians, much is still not known regarding how best to accurately diagnose and effectively treat it. As a result, children and adolescents with bipolar disorder are often symptomatic for long periods of time before receiving appropriate treatment.
View Article and Find Full Text PDF